心不全の心臓再生 テルモ 実用化へ申請 安全審査に１年
TERUMO Corporation has long been working to produce a cell sheet used for the treatment of a heart failure patient, and recently has decided to put the initiative into a practical business stage. To do the business, it is necessary for the company to get the permission by the health ministry. So, TERUMO applied to the ministry for the permission of the production and sales of the cell sheet, on Thursday, October 30. It is likely that the procedure of judgement takes about a year. If there is no problem, in a year or so, the world's first commercial-based production of the cell sheet will be realized.
TERUMO Corporation has long been working to produce a cell sheet used for the treatment of a heart failure patient, and recently has decided to put the initiative into a practical business stage. To do the business, it is necessary for the company to get the permission by the health ministry. So, TERUMO applied to the ministry for the permission of the production and sales of the cell sheet, on Thursday, October 30. It is likely that the procedure of judgement takes about a year. If there is no problem, in a year or so, the world's first commercial-based production of the cell sheet will be realized.
